Literature DB >> 18809386

Sp1-mediated transcription regulation of TAF-Ialpha gene encoding a histone chaperone.

Masamitsu N Asaka1, Kensaku Murano, Kyosuke Nagata.   

Abstract

TAF-I, one of histone chaperones, consists of two subtypes, TAF-Ialpha and TAF-Ibeta. The histone chaperone activity of TAF-I is regulated by dimer patterns of these subtypes. TAF-Ibeta is expressed ubiquitously, while the expression level of TAF-Ialpha with less activity than TAF-Ibeta differs among cell types. It is, therefore, assumed that the expression level of TAF-Ialpha in a cell is important for the TAF-I activity level. Here, we found that TAF-Ialpha and TAF-Ibeta genes are under the control of distinct promoters. Reporter assays and gel shift assays demonstrated that Sp1 binds to three regions in the TAF-Ialpha promoter and two or all mutaions of the three Sp1 binding regions reduced the TAF-Ialpha promoter activity. ChIP assays demonstrated that Sp1 binds to the TAF-Ialpha promoter in vivo. Furthermore, the expression level of TAF-Ialpha mRNA was reduced by knockdown of Sp1 using siRNA method. These studies indicated that the TAF-Ialpha promoter is under the control of Sp1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809386     DOI: 10.1016/j.bbrc.2008.09.053

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Regulation of SET Gene Expression by NFkB.

Authors:  Yi Feng; Xiaoyong Li; Weitao Zhou; Dandan Lou; Daochao Huang; Yanhua Li; Yu Kang; Yan Xiang; Tingyu Li; Weihui Zhou; Weihong Song
Journal:  Mol Neurobiol       Date:  2016-06-28       Impact factor: 5.590

Review 2.  Assembly and remodeling of viral DNA and RNA replicons regulated by cellular molecular chaperones.

Authors:  Takeshi Sekiya; Yifan Hu; Kohsuke Kato; Mitsuru Okuwaki; Atsushi Kawaguchi; Kyosuke Nagata
Journal:  Biophys Rev       Date:  2017-11-22

3.  SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.

Authors:  Dale J Christensen; Youwei Chen; Jessica Oddo; Karen M Matta; Jessica Neil; Evan D Davis; Alicia D Volkheimer; Mark C Lanasa; Daphne R Friedman; Barbara K Goodman; Jon P Gockerman; Louis F Diehl; Carlos M de Castro; Joseph O Moore; Michael P Vitek; J Brice Weinberg
Journal:  Blood       Date:  2011-08-15       Impact factor: 22.113

4.  Upregulation of SET expression by BACE1 and its implications in Down syndrome.

Authors:  Xiaozhu Zhang; Yili Wu; Xiaoling Duan; Wei Chen; Haiyan Zou; Mingming Zhang; Shuting Zhang; Fang Cai; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

5.  Human TAF-Iα promotes oncogenic transformation via enhancement of cell proliferation and suppression of apoptosis.

Authors:  Valentina V Nenasheva; Irina V Makarova; Ekaterina A Stepanenko; Stanislav A Antonov; Ekaterina V Novosadova; Anastasia R Narsullaeva; Larisa V Kozikova; Ekaterina A Polteva; Lyudmila A Sleptsova; Natalya A Shcherbatova; Nella V Khaidarova; Lyudmila E Andreeva; Vyacheslav Z Tarantul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-05-21       Impact factor: 2.416

6.  Zinc Finger and X-Linked Factor (ZFX) Binds to Human SET Transcript 2 Promoter and Transactivates SET Expression.

Authors:  Siliang Xu; Ping Duan; Jinping Li; Tristan Senkowski; Fengbiao Guo; Haibin Chen; Alberto Romero; Yugui Cui; Jiayin Liu; Shi-Wen Jiang
Journal:  Int J Mol Sci       Date:  2016-10-20       Impact factor: 5.923

Review 7.  A comprehensive and perspective view of oncoprotein SET in cancer.

Authors:  Buuvee Bayarkhangai; Suzan Noureldin; Liting Yu; Na Zhao; Yaru Gu; Hanmei Xu; Changying Guo
Journal:  Cancer Med       Date:  2018-05-10       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.